Real-world patient outcomes with Blinatumomab and Inotuzumab in adult relapsed/refractory B-cell acute lymphoblastic leukemia: a retrospective analysis from two Romanian oncology centers

IntroductionThe management of adult relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) remains a significant challenge, with patients presenting particularly poor historical outcomes. Novel immunotherapies, such as Blinatumomab and Inotuzumab, have revived the therapeutic landscape...

Cijeli opis

Bibliografski detalji

Glavni autori:	Ion Antohe, Amalia Titieanu, Vlad Andrei Cianga, Cosmin Minciună, Cătălin Dănăilă, Alina Daniela Tănase, Iuliu Ivanov, Loredana Dragoş, Mihaela Zlei, Mihaela Mențel, Ciprian Tomuleasa, Anamaria Bancos, Manuela Ciocoiu, Angela Dăscălescu
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2025-12-01
Serija:	Frontiers in Pharmacology
Teme:	B-cell acute lymphoblastic leukemia immunotherapy CAR-T cells Blinatumomab Inotuzumab
Online pristup:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1684382/full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!